What is drug tolerance, and why does it matter for people taking prescription medication or psychoactive substances? When the body adapts to a substance over time and begins requiring larger doses to produce the same effect, it can set the stage for physical dependence and, in some cases, a full substance use disorder. Building up a tolerance is easy. For example, the first cup of coffee in the morning used to give you a powerful jolt, but now you need two or three just to feel awake. That experience is a perfect everyday example of tolerance. It’s a natural process, but when it involves medications or other substances, it can be a sign of something more serious.
Tolerance Definition Psychology Drugs
Drug tolerance refers to a person’s diminished response to a substance after repeated use, meaning the same amount of a drug no longer produces the desired effect it once did. As tolerance develops, the brain and body adjust at the level of cell receptors and biochemical pathways, reducing how strongly the substance attaches to its targets and how powerfully it acts on the central nervous system. This process involves liver enzymes involved in metabolizing medications, receptor desensitization, and shifts in the cell’s structure that change how the body reacts to the continued presence of the psychology drug. If you or someone you know has noticed that normal doses no longer work and that substance use is increasing, addiction and substance abuse treatment can help address both the physical and psychological sides of what is happening.
How Does Drug Tolerance Develop?
Developing drug tolerance isn’t a single event but a complex process involving changes in your brain and body. When you repeatedly use a substance, your system works hard to adjust and maintain its natural equilibrium.
Pharmacological Tolerance (Changes in the Body)
When a drug is used regularly, the cell receptors can become less sensitive, a process known as receptor desensitization. It’s like the receptors get tired of the constant stimulation and stop responding as strongly. In some cases, the brain may even reduce the number of receptors available.
This molecular basis means that more of the drug is needed to activate enough receptors to produce the desired effect. Learning about how drugs affect the brain can provide deeper insight into these powerful changes.
Behavioral Tolerance (Learned Responses)
Behavioral tolerance is about learning to function while under the influence of a substance. It’s a learned adaptation where your mind compensates for the drug’s effect. A common example is when someone who drinks alcohol regularly learns to mask the typical signs of intoxication, like slurred speech or an unsteady gait.
Their brain has learned to counteract some of the drug’s impairments, allowing them to appear sober. The environment also plays a role; familiar settings can trigger these learned responses, making the drug’s effect seem weaker than it would in a new situation.
Metabolic Tolerance (Faster Elimination)
Your body, particularly your liver, is designed to break down and eliminate foreign substances. When you use a drug repeatedly, your body can become more efficient at this process. The liver may produce more of the specific enzymes needed to metabolize that substance.
As a result, the drug is cleared from your system much faster. This means the same dose won’t last as long or have as much of an impact, leading you to feel you need more of the substance to achieve the same effect.
Understanding the Different Types of Drug Tolerance
Drug tolerance isn’t a one-size-fits-all phenomenon. It can show up in different ways, depending on the substance, how often it’s used, and your own unique biology. Getting to know these different types can help you better understand what might be happening in your body and why it’s so important to seek professional advice.
Acute and Chronic Tolerance
Not all tolerance takes weeks or months to develop. Acute tolerance refers to the rapid development of tolerance that can occur after just one or a few doses of a substance. You might notice the effects of a drug are weaker after a few hours than they were when you first took it, even if the amount in your bloodstream is the same.
Cross-Tolerance
Cross-tolerance is a fascinating and important concept where developing tolerance to one drug can cause you to have a tolerance to other drugs in the same class. This happens because many drugs work on the same receptors in the brain. Understanding what happens when drugs are combined is crucial for safety, as cross-tolerance can increase the risk of overdose.
Recognizing Withdrawal Symptoms
High tolerance is often a strong indicator of physical dependence, meaning your body has adapted to the presence of the drug to function. When the substance is removed or the dose is lowered, you may experience withdrawal symptoms. This withdrawal syndrome is your body’s way of reacting to the absence of the drug it has come to depend on. Symptoms can range from uncomfortable to severe and may include:
- Anxiety, agitation, or irritability
- Nausea, vomiting, or diarrhea
- Muscle aches and pains
- Tremors or shaking
- Insomnia and fatigue
- Sweating and chills
Treatment Programs
Seeking help for multidrug resistance strains will only help you avoid increased tolerance and lead to dangerous territory.
Medical Detox and Inpatient Care
MPower Wellness does not provide medical detox or inpatient treatment directly, but we recognize that withdrawal syndrome and physical dependence often require a higher level of medical supervision before outpatient care can begin. For clients who need that level of support, we refer to trusted partners with the clinical resources to manage detox safely. Once stabilized, clients are welcome to transition into our programs for continued care.
Partial Hospitalization Program
Our partial hospitalization program Pennsylvania is designed for people who need structured, full-day programming without requiring an overnight stay. It works well for clients stepping down from inpatient treatment or those whose drug dependence and co-occurring conditions require more intensive support than standard outpatient sessions provide.
Outpatient Programs
Our intensive outpatient program Pennsylvania and outpatient rehab Pennsylvania offer flexible treatment schedules that allow clients to remain in their daily routines while receiving consistent clinical support. Both programs include therapy, education about how tolerance develops, and guidance on managing withdrawal symptoms during recovery.
Dual Diagnosis Treatment
Drug tolerance and dependence rarely exist in isolation, and many clients are also managing anxiety, depression, trauma, or other mental health conditions that contributed to their substance use in the first place. Our dual diagnosis treatment centers in PA provide integrated care that addresses both substance use and co-occurring mental health disorders together.
When Tolerance Becomes a Warning Sign
When a specific drug stops working at normal doses and the drive to take larger doses grows stronger, that shift deserves attention, not just a dose increase. Understanding drug tolerance is the first step, but taking action is what truly matters. Help is available, and you don’t have to navigate this journey alone.
MPower Wellness offers a range of treatment programs and mental health services for people navigating drug tolerance, dependence, and the conditions that often come with them. To take the next step, contact us, call (484) 517-3005, or visit us on Google to find our location and hear from people we have helped.
Frequently Asked Questions
Drug tolerance refers to the body’s reduced response to a substance after repeated use, requiring higher doses to achieve the same effect that a lower dose once produced. It develops through changes in cell receptors, liver enzymes, and biochemical pathways that alter how the body processes the drug. Tolerance is not the same as addiction, but it can be an early sign that dependence is developing.
Developing tolerance means the medication’s ability to produce its intended effect has decreased at the current dose, often because the body has adapted to its continued presence. This can lead people to take more than prescribed or to switch to other drugs, both of which carry added risk. Speaking with a prescriber about a drug holiday or a different medication is a safer path than increasing use on one’s own.
Drug tolerance refers to needing more of a substance to feel the same effect, while drug dependence means the body has come to rely on the substance to function normally. Dependence is often marked by withdrawal symptoms when the drug is reduced or stopped. Both can occur together, and both are signs that professional support may be needed.
Tolerance develops more readily with certain classes of substances, particularly psychoactive substances, alcohol, opioids, and benzodiazepines, compared to others like most chemotherapy drugs or antiviral medications, where resistance refers to changes in cancer cells or resistant microorganisms rather than the same neurological process. The molecular basis and speed of tolerance varies by drug and by individual. A prescriber can help identify when tolerance levels are becoming a clinical concern.
Treatment for drug tolerance and the dependence that often follows typically involves a structured substance use disorder program that includes therapy, medical oversight, and support for withdrawal symptoms. Some people benefit from a medically supervised drug holiday or a switch to a different medication class, while others need a full treatment program to address physical dependence safely. The right approach depends on which substance is involved, how long it has been used, and whether co-occurring mental health conditions are present.
Sources
National Cancer Institute. (2011-02-02). Definition of drug tolerance. National Cancer Institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/drug-tolerance
National Center for Biotechnology Information. (2003-12-01). The Molecular Basis of Tolerance. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC3860466/
National Institute on Drug Abuse. (2020-07-06). Treatment and Recovery. National Institute on Drug Abuse. https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery
National Institute on Drug Abuse. (2023-03-22). New NIH study reveals shared genetic markers underlying substance use disorders. National Institute on Drug Abuse. https://nida.nih.gov/news-events/news-releases/2023/03/new-nih-study-reveals-shared-genetic-markers-underlying-substance-use-disorders
Substance Abuse and Mental Health Services Administration. (2025-09-24). Home. Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov
American Society of Addiction Medicine. DSM-5 Criteria for Diagnosis of Opioid Use Disorder. American Society of Addiction Medicine. https://www.asam.org/docs/default-source/education-docs/dsm-5-dx-oud-8-28-2017.pdf
Centers for Disease Control and Prevention. (2022-11-04). CDC Clinical Practice Guideline for Prescribing Opioids for Pain. Centers for Disease Control and Prevention. https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm
University of Florida. (2013-01-01). Substance Use Disorders vs. Substance Abuse and Dependence. University of Florida. https://addiction-certificate.psychiatry.ufl.edu/about-the-program/articles/substance-use-disorders-vs-substance-abuse-and-dependence-dsm-5-changes/
University of Kentucky. (2020-04-27). ACUTE SENSITIVITY AND TOLERANCE TO ALCOHOL AS PREDICTORS OF HEAVY DRINKING. University of Kentucky. https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1178&context=psychology_etds
Hospital for Special Surgery. (2023-07-05). Opioids: Understanding Addiction Versus Dependence. Hospital for Special Surgery. https://www.hss.edu/health-library/conditions-and-treatments/understanding-addiction-versus-dependence
National Center for Biotechnology Information. (2010-01-19). Associations among chronic non-cancer pain patients. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC3000551/
U.S. Department of Labor. (2009-04-01). Risk Factors for Opioid Misuse, Addiction, and Overdose. U.S. Department of Labor. https://www.dol.gov/agencies/owcp/opioids/riskfactors
University of California Los Angeles. A meta-analysis of cognitive behavioral therapy for alcohol or other drug use disorders. University of California Los Angeles. https://addictions.psych.ucla.edu/wp-content/uploads/sites/160/2020/01/JCCP-A-meta-analysis-of-cognitive-behavioral-therapy-for-alcohol-or-other-drug-use-disorders-Treatment-efficacy-by-contrast-condition.pdf
Government of Michigan. Managing Chronic Non-Terminal Pain. Government of Michigan. https://www.michigan.gov/-/media/Project/Websites/lara/healthsystemslicensing/Folder3/UM_Pain_guidelines.pdf?rev=84d1466f7c32425b89c8f76979f4fedd
State of Minnesota. (2024-08-13). Chronic pain opioid prescribing recommendations. State of Minnesota. https://mn.gov/dhs/opip/opioid-guidelines/pain-phase/chronic-pain.jsp
Government of Oregon. How to approach a benzodiazepine taper. Government of Oregon. https://www.oregon.gov/oha/HPA/DSI-Pharmacy/MHCAGDocs/Tapering-Benzodiazepines.pdf
Government of Wyoming. Substance Use Disorder defined by NIDA and SAMHSA. Government of Wyoming. https://wyoleg.gov/InterimCommittee/2020/10-20201105Handoutfor6JtMHSACraig11.4.20.pdf
National Center for Biotechnology Information. (2021-06-09). Acute Tolerance to the Analgesic Effects of Alcohol. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC8328235/
National Center for Biotechnology Information. (2011-10-24). Acute Tolerance to Alcohol in At-risk Binge Drinkers. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC3326440/
Door County, Wisconsin. Criteria for Substance Use Disorders DSM-V. Door County, Wisconsin. https://www.co.door.wi.gov/DocumentCenter/View/2533/Criteria-for-Substance-Use-Disorders-PDF
Drexel University. A. Substance Use Disorders Criteria. Drexel University. https://webcampus.med.drexel.edu/nida/module_2/content/5_0_AbuseOrDependence.htm
Northwestern Oklahoma State University. DSM 5 Substance Use Disorders. Northwestern Oklahoma State University. https://www.nwosu.edu/uploads/academics/social-sciences/bjcc/staff-training/dsm-5-power-point.pdf
National Center for Biotechnology Information. (2023-11-02). Neurobiology of Addiction. PubMed Central. https://www.ncbi.nlm.nih.gov/books/NBK597351/
National Center for Biotechnology Information. (2024-09-02). Withdrawal Syndromes. PubMed Central. https://www.ncbi.nlm.nih.gov/books/NBK459239/
National Center for Biotechnology Information. (2013-08-01). DSM-5 Criteria for Substance Use Disorders. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC3767415/
U.S. Government Publishing Office. Behavioral Tolerance: Research and Treatment Implications. U.S. Government Publishing Office. https://www.govinfo.gov/content/pkg/GOVPUB-HE20-PURL-gpo117646/pdf/GOVPUB-HE20-PURL-gpo117646.pdf
National Center for Biotechnology Information. (2022-04-25). Experiences with benzodiazepine use, tapering, and discontinuation. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC9047812/
National Center for Biotechnology Information. (2009-05-06). Tolerance to Sedative/Hypnotic Actions of GABAergic Drugs. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC2712270/
National Center for Biotechnology Information. (2015-09-01). Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC4606320/
National Center for Biotechnology Information. (2023-12-01). Concurrent opioid and alcohol withdrawal management. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC10696169/
National Library of Medicine. (2000-01-01). Exhibit 2-6, DSM-IV-TR Criteria for Substance Abuse and Dependence. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK92053/table/ch2.t5/
National Center for Biotechnology Information. (1996-01-01). Diagnostic Criteria – Pathways of Addiction. PubMed Central. https://www.ncbi.nlm.nih.gov/books/NBK232974/
National Center for Biotechnology Information. (2021-11-09). Drug dependence is not addiction—and it matters. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC8583742/
National Center for Biotechnology Information. (2015-11-24). Chronic Pain, Chronic Opioid Addiction: a Complex Nexus. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC4781803/
National Center for Biotechnology Information. (2022-08-19). Stimulation holiday rescues analgesia after habituation and loss of sensitization to repeated low-frequency stimulation. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC9613866/
National Center for Biotechnology Information. (2020-08-20). Long-term opioid therapy for chronic noncancer pain. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC7447355/
National Center for Biotechnology Information. (2010-01-01). Cognitive-Behavioral Therapy for Substance Use Disorders. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC2897895/
National Center for Biotechnology Information. (2023-02-19). Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC9948631/
National Center for Biotechnology Information. (2002-05-01). A Behavioral/Systems Approach to the Neuroscience of Drug Addiction. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC6758374/
University of Utah. Genes and Addiction. University of Utah. https://learn.genetics.utah.edu/content/addiction/genes/
National Center for Biotechnology Information. (2012-01-01). Epigenetics of drug abuse: predisposition or response. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC3463407/
National Center for Biotechnology Information. (2021-03-23). Understanding the genetics and neurobiological pathways behind vulnerability to addiction. PubMed Central. https://www.spandidos-publications.com/10.3892/etm.2021.9976
